
Linafien-M 2.5/1000 Tablets by Plena Remedies contain Linagliptin and Metformin Hydrochloride, a combination of oral antidiabetic medicines prescribed for managing Type 2 Diabetes Mellitus in adults.
Linagliptin belongs to the dipeptidyl peptidase-4 (DPP-4) inhibitor class. It works by increasing the activity of incretin hormones, which help stimulate insulin secretion when blood glucose levels are elevated and reduce excessive glucagon secretion.
Metformin Hydrochloride belongs to the biguanide class of antidiabetic medicines. It primarily reduces glucose production in the liver and improves insulin sensitivity, helping the body use glucose more effectively.
The combination of Linagliptin and Metformin helps manage fasting and post-meal blood glucose levels and supports improved HbA1c control when used alongside a balanced diet and regular physical activity.
Linafien-M 2.5/1000 Tablets may be prescribed when blood sugar levels are not adequately controlled with an individual antidiabetic medicine or when combination treatment is considered clinically appropriate.
The medicine should be taken strictly according to a registered medical practitioner's prescription. Dosage and treatment duration depend on the patient's blood glucose levels, kidney function, medical history and response to treatment.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Plena Remedies Pvt. Ltd. is an Indian pharmaceutical and healthcare company.
Key Details
• Incorporation / Establishment: Incorporated on August 22, 2023 (registered under corporate entities as Plena Remedies Private Limited in Himachal Pradesh), with brand origins dating back earlier.
• Registered Office / Location: Plot No. 17, Himuda Ind. Area, Bhatoli Kalan, Baddi, Solan, Himachal Pradesh, 173201, India.
• Leadership / Directors: Munesh Kumar (CEO / Director) and Vijay Singh.
• Certifications: ISO 9001:2015, WHO-GMP, and GLP certified.
• Core Business & Services:
• PCD Pharma Franchise: Offers monopoly-based franchise opportunities across India.
• Third-Party / Contract Manufacturing: Produces bulk formulations for other brands.
• Product Portfolio: 1,500+ certified formulations spanning tablets, capsules, injectables, syrups, dry syrups, ointments, and specialized divisions like pediatric, orthopedic, gynecology, dermatology, cardiology, and nutraceuticals.
• Ecosystem Partners: Associated with sister or collaborative entities like Itelic Labs and Rajora Biotech.